Insights

Strategic JV PharmaMax operates as a China–American joint venture, combining international quality and governance with China’s regulatory execution capabilities, suggesting opportunities for co-development, technology transfer, and dual-market regulatory support.

Chronic Care Focus Portfolio concentrates on high-value prescription and consumer healthcare products for chronic conditions, indicating sales opportunities in long-term therapies, adherence initiatives, and partnerships with payers or distributors targeting chronic disease management.

Expansion Momentum A planned large-scale facility upgrade and headquarters expansion signals capacity growth and potential for new contract manufacturing, private label opportunities, and scalable supply arrangements to meet rising demand.

Global Partnerships Strategic collaborations with US and EU companies to bring breakthrough products to China create avenues for co-marketing, licensing deals, and distribution partnerships to broaden product portfolio coverage.

Commercial Services Turn-key concept-to-commercialization capabilities offer opportunities to engage PharmaMax as a full-service partner for market entry, regulatory filings, and product launches for external clients seeking China market access.

Similar companies to PharmaMax Corporation

PharmaMax Corporation Tech Stack

PharmaMax Corporation uses 8 technology products and services including CNZZ, Babel, Element UI, and more. Explore PharmaMax Corporation's tech stack below.

  • CNZZ
    Analytics
  • Babel
    Development
  • Element UI
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • core-js
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Amap
    Maps
  • Java
    Programming Languages

PharmaMax Corporation's Email Address Formats

PharmaMax Corporation uses at least 1 email format:
PharmaMax Corporation Email FormatsExamplePercentage
First.Last@pharmamaxcorp.comJohn.Doe@pharmamaxcorp.com
100%

Frequently Asked Questions

What is PharmaMax Corporation's official website and social media links?

Minus sign iconPlus sign icon
PharmaMax Corporation's official website is pharmamaxcorp.com and has social profiles on LinkedIn.

How much revenue does PharmaMax Corporation generate?

Minus sign iconPlus sign icon
As of November 2026, PharmaMax Corporation's annual revenue is estimated to be $10M - $25M.

What is PharmaMax Corporation's NAICS code?

Minus sign iconPlus sign icon
PharmaMax Corporation's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PharmaMax Corporation have currently?

Minus sign iconPlus sign icon
As of November 2026, PharmaMax Corporation has approximately 10 employees across 3 continents, including Asia, North America and Europe. Key team members include Vp Of Analytical R&d, Head Of Quality: X. C. Explore PharmaMax Corporation's employee directory with LeadIQ.

What industry does PharmaMax Corporation belong to?

Minus sign iconPlus sign icon
PharmaMax Corporation operates in the Pharmaceutical Manufacturing industry.

What technology does PharmaMax Corporation use?

Minus sign iconPlus sign icon
PharmaMax Corporation's tech stack includes CNZZ, Babel, Element UI, Vue.js, core-js, jQuery, Amap and Java.

What is PharmaMax Corporation's email format?

Minus sign iconPlus sign icon
PharmaMax Corporation's email format typically follows the pattern of First.Last@pharmamaxcorp.com. Find more PharmaMax Corporation email formats with LeadIQ.

When was PharmaMax Corporation founded?

Minus sign iconPlus sign icon
PharmaMax Corporation was founded in 2009.
PharmaMax Corporation logo

PharmaMax Corporation

Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees

PharmaMax Corporation operates in pharmaceutical manufacturing, focusing on high-value prescription and consumer health products designed to treat chronic conditions. It is a China-American joint venture between Jiangsu Changtai LTD and PharmaMax USA, integrating international quality standards with operations in China.

An international management team has developed and commercialized more than 250 new products for the global marketplace, and the company also provides turn-key concept-to-commercialization services to other customers. The company is based in Taizhou City, Jiangsu Province, China, with a presence in Rockaway, New Jersey, United States, reflecting its cross-border structure. Its facilities are located in Taizhou City within the Chinese Medical City, currently comprising 3,000 square meters for research, development, and cGMP manufacturing, with expansion plans to 16,000 square meters and a new headquarters in early 2015.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
2-10

Section iconFunding & Financials

  • $10M - $25M

    PharmaMax Corporation's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.